Related references
Note: Only part of the references are listed.Proteins: molecules defined by their trade-offs
Lavi S. Bigman et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2020)
Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitors
Georg Dultz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Near-Neighbor Interactions in the NS3-4A Protease of HCV Impact Replicative Fitness of Drug-Resistant Viral Variants
Nadezhda T. Doncheva et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Effects of the Q80K Polymorphism on the Physicochemical Properties of Hepatitis C Virus Subtype 1a NS3 Protease
Allan Peres-da-Silva et al.
VIRUSES-BASEL (2019)
HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape
Long V. Pham et al.
JOURNAL OF HEPATOLOGY (2019)
Impact of hepatitis C virus polymorphisms on direct-acting antiviral treatment efficacy: Regulatory analyses and perspectives
Patrick R. Harrington et al.
HEPATOLOGY (2018)
Modulation of the Allosteric Communication between the Polo-Box Domain and the Catalytic Domain in Plk1 by Small Compounds
Monika Raab et al.
ACS CHEMICAL BIOLOGY (2018)
Unexpected Replication Boost by Simeprevir for Simeprevir-Resistant Variants in Genotype 1a Hepatitis C Virus
Kazuhisa Murai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
Julia Dietz et al.
GASTROENTEROLOGY (2018)
Stability of the Influenza Virus Hemagglutinin Protein Correlates with Evolutionary Dynamics
Eili Y. Klein et al.
MSPHERE (2018)
Stability Effects of Protein Mutations: The Role of Long-Range Contacts
Lavi S. Bigman et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2018)
Influence of protein fold stability on immunogenicity and its implications for vaccine design
Sandra Scheiblhofer et al.
EXPERT REVIEW OF VACCINES (2017)
Biomolecular coevolution and its applications: Going from structure prediction toward signaling, epistasis, and function
Mehari B. Zerihun et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants
Thierry Verbinnen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region
Christoph Sarrazin et al.
ANTIVIRAL RESEARCH (2015)
Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage
Christoph Welsch et al.
JOURNAL OF HEPATOLOGY (2015)
Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies
Oliver Lenz et al.
JOURNAL OF HEPATOLOGY (2015)
Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle
David R. McGivern et al.
JOURNAL OF VIROLOGY (2015)
Global Origin and Transmission of Hepatitis C Virus Nonstructural Protein 3 Q80K Polymorphism
Rosemary M. McCloskey et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Comparing Molecular Dynamics Force Fields in the Essential Subspace
Fernando Martin-Garcia et al.
PLOS ONE (2015)
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
Julie Sheldon et al.
JOURNAL OF VIROLOGY (2014)
The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection
Ralf Bartenschlager et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Peptidomimetic Escape Mechanisms Arise via Genetic Diversity in the Ligand-Binding Site of the Hepatitis C Virus NS3/4A Serine Protease
Christoph Welsch et al.
GASTROENTEROLOGY (2012)
Viral Quasispecies Evolution
Esteban Domingo et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Rapid Antigen Processing and Presentation of a Protective and Immunodominant HLA-B*27-restricted Hepatitis C Virus-specific CD8+ T-cell Epitope
Julia Schmidt et al.
PLOS PATHOGENS (2012)
Protease Inhibitor-Resistant Hepatitis C Virus Mutants With Reduced Fitness From Impaired Production of Infectious Virus
Tetsuro Shimakami et al.
GASTROENTEROLOGY (2011)
Analyzing and visualizing residue networks of protein structures
Nadezhda T. Doncheva et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics
J. Guedj et al.
JOURNAL OF THEORETICAL BIOLOGY (2010)
SeaView Version 4: A Multiplatform Graphical User Interface for Sequence Alignment and Phylogenetic Tree Building
Manolo Gouy et al.
MOLECULAR BIOLOGY AND EVOLUTION (2010)
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding
Keith P. Romano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
Libin Rong et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Epistatic Interactions
Tyler J. VanderWeele
STATISTICAL APPLICATIONS IN GENETICS AND MOLECULAR BIOLOGY (2010)
Molecular targets for flavivirus drug discovery
Aruna Sampath et al.
ANTIVIRAL RESEARCH (2009)
Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 Helicase
Rudolf K. F. Beran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
P-LINCS: A parallel linear constraint solver for molecular simulation
Berk Hess
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations
In Suk Joung et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2008)
NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly
Yinghong Ma et al.
JOURNAL OF VIROLOGY (2008)
Protein stability imposes limits on organism complexity and speed of molecular evolution
Konstantin B. Zeldovich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)
euHCVdb: the European hepatitis C virus database
Christophe Combet et al.
NUCLEIC ACIDS RESEARCH (2007)
Comparison of multiple amber force fields and development of improved protein backbone parameters
Viktor Hornak et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor - Reduced rna replication fitness and partial rescue by second-site mutations
MK Yi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells
M Yi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Relation between viral fitness and immune escape within the hepatitis C virus protease
J Söderholm et al.
GUT (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
E Meylan et al.
NATURE (2005)
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
T Kawai et al.
NATURE IMMUNOLOGY (2005)
VISA is an adapter protein required for virus-triggered IFN-β signaling
LG Xu et al.
MOLECULAR CELL (2005)
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3
RB Seth et al.
CELL (2005)
The FoldX web server: an online force field
J Schymkowitz et al.
NUCLEIC ACIDS RESEARCH (2005)
Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients
S Vallet et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins
OB Engler et al.
VACCINE (2004)